首页> 外文期刊>Journal of atherosclerosis and thrombosis. >Testing Endothelial Function and its Clinical Relevance
【24h】

Testing Endothelial Function and its Clinical Relevance

机译:检测内皮功能及其临床意义

获取原文
       

摘要

Endothelial dysfunction as an integrating index of the risk factor burden and genetic susceptibility is an early marker of atherothrombotic disease. Therefore, tremendous interest exists in its measurement and determination of the clinical utility of the evaluation of endothelial function. Different invasive and non-invasive techniques exist for exploring various aspects of the pathobiology of the endothelium. As endothelial dysfunction is a diffuse-systemic disorder, the peripheral arteries, because of their accessibility, represent the basis for assessment of endothelial dysfunction. Flow-mediated dilation (FMD) of the peripheral conduit arteries is one of the most widely used tests of endothelial function. FMD measures the endothelial vasomotor response during reactive hyperemia, but it does not provide information concerning the control of arterial tone at rest. A new technique, low-flow-mediated constriction (L-FMC), provides complementary information to that by FMD, quantifying the decrease in the forearm conduit artery diameter that occurs in response to the decrease in blood flow during occlusion. This indicated that the L-FMC response is not based on nitric oxide availability but it might be mediated by other substances, providing a coordinated effect of vasodilation and its inhibition; therefore, simultaneous determination of FMD and L-FMC may provide comprehensive information on vascular homeostasis. Peripheral arterial tonometry (PAT) evaluates pulse wave amplitude, which is linked to endothelial function. Like FMD, PAT has also been shown to be reduced in the presence of risk factors, as well as in patients with atherosclerosis; however, FMD of the brachial artery and PAT are very different methods for identification of the vascular reactivity of different arterial territories. FMD directly registers the dilation capability of the large-conduit artery, whereas PAT measures flow response hyperemia, which is related to the endothelial function of small arteries and to the endothelial function of the microcirculation. Therefore, this technique is mostly used for investigation of the functional capability of the microcirculation. Determination of venous endothelial dysfunction is more complicated and invasive and is less reproducible. Micro-invasive techniques such as the dorsal hand vein technique and radionuclide assessment of changes in volume of the legs provide limited information about venous endothelial health; however, as endothelial dysfunction is expected to be a systemic disorder affecting the complete circulatory system, determination of the endothelial function of peripheral arteries also gives insight into venous functional status.
机译:内皮功能障碍是危险因素负担和遗传易感性的综合指标,是动脉粥样硬化血栓形成疾病的早期标志。因此,对其测量和确定内皮功能评估的临床效用存在极大的兴趣。存在用于探索内皮病理生物学的各个方面的不同的侵入性和非侵入性技术。由于内皮功能障碍是一种弥散性系统疾病,因此外周动脉由于其可及性而成为评估内皮功能障碍的基础。外周导管动脉的血流介导的扩张(FMD)是最广泛使用的内皮功能测试之一。 FMD测量反应性充血期间的内皮血管舒缩反应,但未提供有关静息动脉张力控制的信息。低流量介导的收缩(L-FMC)是一项新技术,可通过FMD提供补充信息,从而量化因阻塞期间血流减少而发生的前臂导管动脉直径的减少。这表明L-FMC反应不是基于一氧化氮的可利用性,而是可能由其他物质介导,提供了血管舒张及其抑制的协同作用。因此,同时测定FMD和L-FMC可能提供有关血管稳态的全面信息。外周动脉眼压计(PAT)评估脉搏波幅度,该幅度与内皮功能有关。与FMD一样,在存在危险因素以及动脉粥样硬化的患者中,PAT也已被降低。然而,肱动脉的口蹄疫和PAT是鉴别不同动脉区域血管反应性的非常不同的方法。 FMD直接记录大导管的扩张能力,而PAT测量流量反应性充血,这与小动脉的内皮功能和微循环的内皮功能有关。因此,该技术主要用于研究微循环的功能。静脉内皮功能障碍的测定更为复杂,侵入性强,重复性差。诸如手背静脉技术和放射性核素对腿部体积变化的评估等微创技术提供的有关静脉内皮健康的信息有限;然而,由于内皮功能障碍可能是影响整个循环系统的全身性疾病,因此确定外周动脉的内皮功能也可以洞悉静脉功能状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号